Tabagismo e saúde bucal

Jornal Brasileiro de Pneumologia

Volumn 30, Issue SUPPL. 2, 2004, Pages

  Botelho, Clovis ^a   Castillo, Patrícia Leão ^a   Ayoub, Letícia Teixeira Vitale ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 45349093784     PISSN: 18063713     EISSN: 18063713     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Jones RB. Tobacco or oral health: past progress, impending challenge. J Am Dent Assoc 2000;131:1130-45.
2. Sheiham A, Moysés SJ. O papel dos professionais de saúde bucal na promoção da saúde. In: Buischi YP. Promoção de saúde bucal na clínica odontológica. São Paulo: Artes Médicas; 2000;22:23-36.
3. Araújo S N. Patologia bucal. São Paulo: Artes Médicas; 1984;127-30.
4. a ed. São Paulo, Guanabara Koogan, 1998.
5. Souza FG, Brandão A, Almeida J, Rosa LE. Alterações genéticas e câncer bucal: uma breve revisão. Rev Bras Patol Oral 2004;3:20-5.
6. Petersen P E. Tobacco and oral health - The role of the world health organization. Oral Health Prev Dent 2003;1:309-15.
7. CDC. The health consequences of smoking. Surgeon General's Report, 2004;2:63-7.
8. Silverman S Jr. Leukoplakia and erythroplakia. In: Oral Cancer. Hamilton (Canada), B.C. Decker, 1998;25-40.
9. Bouquot JE. Oral leukolakia and erythroplakia: a review and update. Pract Periodont Austh Dent 1994;6:9-17.
10. Kresty LA, Carmella SG, Borukhova A, Akerkar SA, Gopalakrishnan R, Harris RE, et al. Metabolites of a tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanona (NNK), in the urine of smokless tobacco users: relationship between urinary biomarkers and oral leukoplakia. Cancer Epi Biomarkers Prev 1996;5:521-5.
11. Stich HF, Parida BB, Brunnemann KD. Localized formation of micronuclei in the oral mucosa and tobacco-specific nitrosamines in the saliva of "reverse" smokers, khaini-tobacco chewers and gudakhu users. Int J Cancer 1992;50:172-6.
12. Ames BN, Gold LS, Willett WC. The causes and prevention of cancer. Proc Natl Acad Sci USA 1995;92:5258-65
13. Asami S, Manabe H, Miyake J, Tsudorme Y, Hirano T, Yamaguchi R, et al. Cigarette smoking induces an increase in oxidative DMA damage, 8- hydroxydeoxyguanosine, in a central site of the human lung. Carcinogenesis 1997;18:1763-6.
14. Brennan JA, Boyle JO, Koch WM, Goodman SN, Hruban RH, Eby YJ, et al. Association between cigarette smoking and mutation of p53 gene in squamous-cell carcinoma of the head and neck. N Engl J Med 1995;332:712-7.
15. Schrek R, Baker LA, Ballard GF, Dolgoff S. Tobacco smoking as an etiologic factor in disease cancer. Cancer Res 1950;10:49-58.
16. Ministério da Saúde, Instituto Nacional do Câncer (INCA). Tabagismo. Brasília: INCA, 2003, 20 p.
17. Genco RJ. Current view of risk factors for periodontal diseases. J Periodontol 1996;67(Suppl):1041-9.
18. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
19. Genco RJ. Classification and clinical and radiografic features of periodontal disease. In: Genco RJ, Goldmann HM, Cohen DW, editors. Contemporary Periodontics. St Louis: CV Mosby, 1990;63-81.
20. Genco RJ. Risk factors for periodontal disease. In: Rose LF, Genco RJ, Cohen DW, Mealey BL, editors. Periodontal Medicine. St Louis: Mosby, 2000;11-3.
21. Lavstedt S, Modeer T, Welander E. Plaque and gingivitis in a group of Swedish schoolchildren with special reference to toothbrushing habits. Acta Odont Scand 1982;40:307-11.
22. Preber H, Linder L, Bergstrom J. Periodontal healing and peripathogenic microflora in smokers and non-smokers. J Clin Periodontol 1995;22:946-52.
23. Shiloah J, Patters Mr, Waring MB. The prevalence of pathogenic periodontal microflora in healthy young adult smokers. J Periodontol 2000;71:562-7.
24. Sayers NM, James JA, Drucker DB, Blinkhorn AS. Posible potentiation of toxins fron Preotella intermedia, Provetella nigrescens, and Porphyromonas gingivalis by cotinine. J Periodontol 1999;70:1269-7.
25. Quinn Sm, Zhang JB, Gunsolley JC, Schenkein HA, Tew JG. The influence of smoking and race on adult periodotitis and serum IgG2 levels. J Periodontol 1998;69:171-7.
26. Bostrom L, Linder LE, Bergstrom J. Clinical expression of TNF in smoking-associated periodontal disease. J Clin Periodontol 1998;25:767-73.
27. Tipton DA, Dabbous MK. Effects of nicotine on proliferation and extracellular matrix production of human gingival fibroblasts in vitro. J Periodontol 1995;66:1056-64.
28. Faddy MJ, Cullinan MP, Palmer JE, Westerman B, Seymour GJ. Ante-dependence modeling in a longitudinal study of periodontal disease: the effect of age, gender and smoking status. J Periodontol 2000;71:454-9.
29. Little J, Cardy A, Munger RG. Tobacco smoking and oral clefts: a meta-analysis. Bulletin WHO, 2004;82:213-22.
30. Featherstone JOB. Prevention and reversal of dental caries: role of low level fluoride. Comm Dent Oral Epidemiol 1999;27:31-40.
31. US Department of Health an Human Services. Oral Health in America: a report of the health consequences of smoking. Surgeon General's Report 2000;6:732-65.
32. Andrews JÁ, Severson HH, Lichtenstein E, Gordon JS. Relatioship between tobacco use and self-reported oral hygiene habits. J Am Dent Assoc 1998;129:313-20.
33. Migliari DA, Marcucci G. Níveis de IgA secretória na saliva total não estimulada de indivíduos fumantes e não fumantes por imunodifusão radial simples. Rev Odontol USP 1993;7:109-13.
34. Martin GC, Brown JP, Eifler CW, Houston GD. Oral leukoplakia status six weeks after cessation of smokeless tobacco use. J Am Dent Assoc 1999;130:945-53.
35. Johnson NW, Bain CA. Tobacco and oral disease. Brit Dent J 2000;24:200-6.
36. Graça NJF, Graça TCA. Avaliação dos efeitos nocivos do fumo na osseointegração. Rev Bras Implant 1997;3:20-2.
37. Sham AS, Cheung LK, Jin LJ, Corbel EF. The effects of tobacco use on oral health. Hong Kong Med J 2003;9:271-7.